Gandini R - Search Results

1

[Effects of isosorbide-5-mononitrate on exercise capacity, prostacyclin synthesis, the renin-aldosterone axis and catecholamines in patients with cardiac insufficiency].

Gandini R, Baggio E, Pozzoli G, Massari D, Megali R, Vargiu B, Maraffi F, Assereto R, Montella S. Gandini R, et al. Cardiologia. 1989 May;34(5):447-53. Cardiologia. 1989. PMID: 2758447 Italian.

2

[Pharmacokinetics and bioavailability of a new slow-release isosorbide-5-mononitrate system].

Gandini R, Cunietti E, Assereto R, Castoldi D, Tofanetti O, Baggio E. Gandini R, et al. Cardiologia. 1987 Nov;32(11):1287-91. Cardiologia. 1987. PMID: 3447701 Italian. No abstract available.

3

Pharmacokinetics of isosorbide mononitrate in a new sustained release oral form in comparison with a conventional formulation.

Gandini R, Cunietti E, Assereto R, Castoldi D, Tofanetti O, Baggio E. Gandini R, et al. Arzneimittelforschung. 1987 Jul;37(7):836-9. Arzneimittelforschung. 1987. PMID: 3675680

4

Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure (interim analysis). The CoQ10 Drug Surveillance Investigators.

Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Baggio E, et al. Among authors: gandini r. Clin Investig. 1993;71(8 Suppl):S145-9. doi: 10.1007/BF00226857. Clin Investig. 1993. PMID: 8241700

5

Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators.

Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Baggio E, et al. Among authors: gandini r. Mol Aspects Med. 1994;15 Suppl:s287-94. doi: 10.1016/0098-2997(94)90040-x. Mol Aspects Med. 1994. PMID: 7752841 Clinical Trial.

6

The effect of simvastatin on HDL cholesterol in hyperlipidemic patients. Evidence of a relationship with the changes in serum triglyceride level.

Branchi A, Rovellini A, Fiorenza AM, Maraffi F, Gandini R, Sommariva D. Branchi A, et al. Among authors: gandini r. Int J Clin Pharmacol Ther. 1996 Sep;34(9):384-9. Int J Clin Pharmacol Ther. 1996. PMID: 8880287

7

Fluorescence-determined kinetics of plasma high oxidability in diabetic patients.

Cestaro B, Gandini R, Viani P, Maraffi F, Cervato G, Montalto C, Gatti P, Megali R. Cestaro B, et al. Among authors: gandini r. Biochem Mol Biol Int. 1994 Apr;32(5):983-94. Biochem Mol Biol Int. 1994. PMID: 8069247

8

Normal and slow-release formulations of bezafibrate: a comparative pharmacokinetic study in man.

Gandini R, Assereto R, Castoldi D, Cunietti E, Garanzelli P, Monzani W. Gandini R, et al. Int J Clin Pharmacol Res. 1987;7(2):149-55. Int J Clin Pharmacol Res. 1987. PMID: 3583496

9

Effects of slow release bezafibrate on the lipid pattern and on blood glucose of type 2 diabetic patients with hyperlipidaemia.

Rovellini A, Sommariva D, Branchi A, Maraffi F, Montalto C, Gandini R, Fasoli A. Rovellini A, et al. Among authors: gandini r. Pharmacol Res. 1992 Apr;25(3):237-45. doi: 10.1016/s1043-6618(05)80072-6. Pharmacol Res. 1992. PMID: 1518767

10

[Significance of certain neoplastic markers in a series of patients with lung cancer].

Cunietti E, Locatelli E, Vaiani G, Baggio E, Gandini MC, Gandini R, Fasoli A. Cunietti E, et al. Among authors: gandini r, gandini mc. Minerva Med. 1984 Apr 28;75(18):1041-6. Minerva Med. 1984. PMID: 6328365 Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters